What is the recommended dosage and treatment protocol for lisinopril (Angiotensin-Converting Enzyme inhibitor) in patients with hypertension or heart failure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lisinopril Dosage and Treatment Protocol for Hypertension and Heart Failure

For hypertension, the recommended initial dose of lisinopril is 10 mg once daily, with a usual dosage range of 20-40 mg once daily; for heart failure, start with 5 mg once daily (or 2.5 mg if hyponatremic) and titrate to a maximum of 40 mg once daily. 1

Dosing for Hypertension

Initial Therapy

  • Initial dose: 10 mg once daily 1
  • Usual maintenance range: 20-40 mg once daily 1
  • Maximum dose: Up to 80 mg daily has been used, but with minimal additional benefit 2, 1

Special Situations

  • With diuretics: Start with 5 mg once daily 1
  • Consider reducing or withholding diuretics for 24 hours before starting to minimize first-dose hypotension 2
  • Pediatric patients (≥6 years):
    • Initial: 0.07 mg/kg once daily (up to 5 mg total)
    • Maximum: 0.61 mg/kg once daily (up to 40 mg) 1

Dosing for Heart Failure

Initial Therapy

  • Standard initial dose: 5 mg once daily 1
  • With hyponatremia (serum sodium <130 mEq/L): 2.5 mg once daily 1
  • Target dose: 20 mg once daily 3

Titration Schedule

  • Increase dose at intervals of at least 2 weeks 3, 2
  • Typical titration: Double the dose at each step (e.g., 5 mg → 10 mg → 20 mg → 40 mg) 3
  • Maximum dose: 40 mg once daily 1

Dosing for Post-Myocardial Infarction

  • Initial dose: 5 mg orally
  • Titration: 5 mg after 24 hours, 10 mg after 48 hours, then 10 mg once daily
  • Duration: Continue for at least 6 weeks
  • With low systolic BP (≤120 mmHg and >100 mmHg): Start with 2.5 mg 1

Renal Impairment Adjustments

  • CrCl >30 mL/min: No adjustment needed
  • CrCl 10-30 mL/min: Start with half the usual dose
    • Hypertension: 5 mg
    • Heart failure: 2.5 mg
  • CrCl <10 mL/min or hemodialysis: Initial dose 2.5 mg once daily 1, 4

Monitoring Protocol

Initial Phase

  • Check blood pressure, renal function, and electrolytes 1-2 weeks after each dose increase 2
  • Monitor for first-dose hypotension, especially in patients:
    • On diuretics
    • Volume-depleted
    • With heart failure
    • With renal impairment 1

Maintenance Phase

  • Check blood pressure, renal function, and electrolytes at 3 months after reaching maintenance dose
  • Continue monitoring every 6 months thereafter 2
  • An increase in creatinine up to 50% or to 3 mg/dL is acceptable 2

Important Contraindications

  • History of angioedema with previous ACE inhibitor use 3
  • Pregnancy 3
  • Bilateral renal artery stenosis 3, 2

Common Side Effects to Monitor

  • Cough (occurs in up to 20% of patients) 3, 5
  • Dizziness, headache 5
  • Hypotension 1, 5
  • Hyperkalemia 2
  • Worsening renal function 2, 6

Clinical Pearls

  • Diuretic dose may need adjustment to minimize hypovolemia and hypotension 1
  • Avoid potassium-sparing diuretics during initiation 2
  • Avoid NSAIDs and COX-2 inhibitors if possible 2
  • Transient hypotension after initial dose does not preclude continued therapy 1
  • In the ATLAS study, higher doses of lisinopril (32.5-35 mg daily) showed better outcomes than lower doses (2.5-5 mg daily) in heart failure patients 6

By following these evidence-based dosing and monitoring recommendations, lisinopril can be effectively and safely used to manage both hypertension and heart failure, with appropriate dose adjustments for special populations.

References

Guideline

Hypertension and Heart Failure Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lisinopril in hypertension associated with renal impairment.

Journal of cardiovascular pharmacology, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.